Showing results (61-70 of 7,343) with videos related to
Sort By:
Pageof 735
Journal of Inorganic Biochemistry|December 30, 2015
Chromogenic nitrophenolate-based substrates for light-driven hybrid P450 BM3 enzyme assayQuan Lam, Alejandro Cortez, Thanh Truc Nguyen, et al.Journal of Inorganic Biochemistry|January 30, 2016
EPR spectroscopic characterization of a monomeric PtIII species produced via electrochemical oxidation of the anticancer compound trans-[PtII{(p-HC6F4)NCH2CH2NEt2}Cl(py)]Ruchika Ojha, John F Boas, Glen B Deacon, et al.Journal of Inorganic Biochemistry|January 31, 2016
The structures, cytotoxicity, apoptosis and molecular docking controlled by the aliphatic chain of palladium(II) complexesMingChang Zhu, Xiaoting Cui, Shaozhong Zhang, et al.Journal of Inorganic Biochemistry|January 31, 2016
Apomaghemite as a doxorubicin carrier for anticancer drug deliveryRocío Jurado, Paulina Frączek, Mélissa Droetto, et al.Journal of Inorganic Biochemistry|February 1, 2016
Complexation and molecular modeling studies of europium(III)-gallic acid-amino acid complexesMohamed Taha, Imran Khan, João A P CoutinhoJournal of Inorganic Biochemistry|February 2, 2016
Bovine serum albumin binding, antioxidant and anticancer properties of an oxidovanadium(IV) complex with luteolinLuciana G Naso, Luis Lezama, María Valcarcel, et al.Journal of Inorganic Biochemistry|January 18, 2016
Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligandsNicola Margiotta, Salvatore Savino, Cristina Marzano, et al.Journal of Inorganic Biochemistry|January 18, 2016
Synthesis and structure elucidation of new μ-oxamido-bridged dicopper(II) complexes showing in vitro anticancer activity: Evaluation of DNA/protein-binding properties by experiment and molecular dockingKang Zheng, Fang Liu, Yan-Tuan Li, et al.Journal of Inorganic Biochemistry|January 18, 2016
Dinuclear ruthenium complexes display loop isomer selectivity to c-MYC DNA G-quadriplex and exhibit anti-tumour activityChuping Zheng, Yanan Liu, Ying Liu, et al.Journal of Inorganic Biochemistry|January 20, 2016
ATOX1 gene silencing increases susceptibility to anticancer therapy based on copper ionophores or chelating drugsVincenza Barresi, Giorgia Spampinato, Nicolò Musso, et al.Pageof 735